TY - JOUR
AU - L. Cooper
AU - J. G. Rosen
AU - L. Zhang
AU - D. Pelaez
AU - P. F. Olatunde
AU - J. Owczarzak
AU - J. N. Park
AU - J. L. Glick
A1 - 
AD - Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.; , Oakland, USA.; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.; Division of General Internal Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Center for Biomedical Research Excellence on Opioids and Overdose, Rhode Island Hospital, Providence, RI, USA.; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. jglick5@jhu.edu.
AN - 37296423
BT - Harm Reduct J
C5 - Opioids & Substance Use; HIT & Telehealth; Healthcare Disparities
CP - 1
DA - Jun 9
DO - 10.1186/s12954-023-00793-y
DP - NLM
ET - 20230609
IS - 1
JF - Harm Reduct J
LA - eng
PY - 2023
SN - 1477-7517
SP - 71
ST - Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
T1 - Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
T2 - Harm Reduct J
TI - Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
U1 - Opioids & Substance Use; HIT & Telehealth; Healthcare Disparities
U3 - 10.1186/s12954-023-00793-y
VL - 20
VO - 1477-7517
Y1 - 2023
ER -